Literature DB >> 20345720

von Willebrand factor propeptide and the occurrence of a first ischemic stroke.

M C van Schie, M P M DE Maat, D W J Dippel, P G de Groot, P J Lenting, F W G Leebeek, M J Hollestelle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20345720     DOI： 10.1111/j.1538-7836.2010.03863.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  9 in total

Review 1.  von Willebrand factor: an emerging target in stroke therapy.

Authors:  Simon F De Meyer; Guido Stoll; Denisa D Wagner; Christoph Kleinschnitz
Journal:  Stroke       Date:  2011-12-15       Impact factor: 7.914

2.  Prothrombotic risk factors and antithrombotic therapy in children with ischemic stroke.

Authors:  Azza A Eltayeb; Gamal A Askar; Naglaa H Abu Faddan; Taghreed M Kamal
Journal:  Ther Adv Neurol Disord       Date:  2015-03       Impact factor: 6.570

3.  von Willebrand factor propeptide: biology and clinical utility.

Authors:  Sandra L Haberichter
Journal:  Blood       Date:  2015-07-27       Impact factor: 22.113

Review 4.  Targeting von Willebrand Factor in Ischaemic Stroke: Focus on Clinical Evidence.

Authors:  Nina Buchtele; Michael Schwameis; James C Gilbert; Christian Schörgenhofer; Bernd Jilma
Journal:  Thromb Haemost       Date:  2018-05-30       Impact factor: 5.249

5.  A novel snake venom-derived GPIb antagonist, anfibatide, protects mice from acute experimental ischaemic stroke and reperfusion injury.

Authors:  Ting-Ting Li; Man-Li Fan; Shi-Xiang Hou; Xiao-Yi Li; Devin M Barry; Hui Jin; Sheng-Yong Luo; Feng Kong; Lit-Fui Lau; Xiang-Rong Dai; Guo-Hui Zhang; Lan-Lan Zhou
Journal:  Br J Pharmacol       Date:  2015-06-12       Impact factor: 8.739

6.  von Willebrand Factor Antigen, von Willebrand Factor Propeptide, and ADAMTS13 in Carotid Stenosis and Their Relationship with Cerebral Microemboli.

Authors:  Stephen J X Murphy; Soon Tjin Lim; Fionnuala Hickey; Justin A Kinsella; Deirdre R Smith; Sean Tierney; Bridget Egan; T Martin Feeley; Sinéad M Murphy; D Rónán Collins; Tara Coughlan; Desmond O'Neill; Joseph A Harbison; Prakash Madhavan; Sean M O'Neill; Mary-Paula Colgan; James S O'Donnell; Jamie M O'Sullivan; George Hamilton; Dominick J H McCabe
Journal:  Thromb Haemost       Date:  2020-09-15       Impact factor: 5.249

7.  von Willebrand Factor Propeptide: A Potential Disease Biomarker Not Affected by ABO Blood Groups.

Authors:  Mahat Marianor; Abdullah Wan Zaidah; Ch Che Maraina
Journal:  Biomark Insights       Date:  2015-08-23

8.  Prognostic Hemostasis Biomarkers in Acute Ischemic Stroke.

Authors:  Samantha J Donkel; Boutaina Benaddi; Diederik W J Dippel; Hugo Ten Cate; Moniek P M de Maat
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-03       Impact factor: 8.311

9.  Von Willebrand factor, ADAMTS13 and mortality in dialysis patients.

Authors:  Gurbey Ocak; Mark Roest; Marianne C Verhaar; Maarten B Rookmaaker; Peter J Blankestijn; Willem Jan W Bos; Rob Fijnheer; Nathalie C Péquériaux; Friedo W Dekker
Journal:  BMC Nephrol       Date:  2021-06-16       Impact factor: 2.388
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.